Usana Health Sciences Q1 2024 GAAP EPS $0.86 Beats $0.69 Estimate, Sales $227.800M Beat $226.853M Estimate
Portfolio Pulse from Benzinga Newsdesk
Usana Health Sciences (NYSE:USNA) reported Q1 2024 earnings of $0.86 per share, surpassing the $0.69 estimate, and sales of $227.800M, slightly above the $226.853M estimate. However, both earnings and sales saw a decrease compared to the same period last year, with earnings down 9.47% and sales down 8.28%.
April 30, 2024 | 8:44 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Usana Health Sciences reported higher-than-expected Q1 2024 earnings and sales, but both metrics declined from the previous year.
Beating earnings and sales estimates typically has a positive short-term impact on a company's stock price. However, the year-over-year decline in both earnings and sales might temper investor enthusiasm, suggesting a cautious optimism.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100